Interestingly, Losy et al. (28) found no increase of serum CXCL1 levels in AIS patients within 24 h after onset, instead advocated CXCL1 local but not systemic production of inflammatory response to AIS. Here, CXCL1 is linked to androgen insensitivity syndrome.